DK122662B - Analogifremgangsmåde til fremstilling af terapeutisk aktive sulfonanilider eller syreadditionssalte eller metalsalte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af terapeutisk aktive sulfonanilider eller syreadditionssalte eller metalsalte deraf.

Info

Publication number
DK122662B
DK122662B DK31663AA DK31663A DK122662B DK 122662 B DK122662 B DK 122662B DK 31663A A DK31663A A DK 31663AA DK 31663 A DK31663 A DK 31663A DK 122662 B DK122662 B DK 122662B
Authority
DK
Denmark
Prior art keywords
sulfonanilides
preparation
acid addition
therapeutically active
analogous process
Prior art date
Application number
DK31663AA
Other languages
Danish (da)
English (en)
Inventor
A Larsen
R Uloth
Original Assignee
Mead Johnson & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mead Johnson & Co filed Critical Mead Johnson & Co
Publication of DK122662B publication Critical patent/DK122662B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/05—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/18—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK31663AA 1962-01-24 1963-01-23 Analogifremgangsmåde til fremstilling af terapeutisk aktive sulfonanilider eller syreadditionssalte eller metalsalte deraf. DK122662B (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16849862A 1962-01-24 1962-01-24
US24459762A 1962-12-14 1962-12-14
US38550464A 1964-07-27 1964-07-27
US439086A US3341584A (en) 1962-01-24 1965-03-11 Anilides

Publications (1)

Publication Number Publication Date
DK122662B true DK122662B (da) 1972-03-27

Family

ID=27496795

Family Applications (1)

Application Number Title Priority Date Filing Date
DK31663AA DK122662B (da) 1962-01-24 1963-01-23 Analogifremgangsmåde til fremstilling af terapeutisk aktive sulfonanilider eller syreadditionssalte eller metalsalte deraf.

Country Status (9)

Country Link
US (1) US3341584A (de)
BR (1) BR6346374D0 (de)
CH (1) CH475962A (de)
DE (1) DE1493955B2 (de)
DK (1) DK122662B (de)
FR (4) FR1599658A (de)
GB (1) GB993584A (de)
NL (1) NL139523B (de)
SE (1) SE334368B (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3759993A (en) * 1971-09-27 1973-09-18 Riker Laboratories Inc Fluoromethanesulfonic acid derivatives
US3919424A (en) * 1972-02-16 1975-11-11 Mead Johnson & Co Bronchodilator process and composition
US3993776A (en) * 1973-10-15 1976-11-23 Mead Johnson & Company Anorexigenic process and composition
US3979514A (en) * 1974-08-26 1976-09-07 Mead Johnson & Company Process for interrupting pregnancy with sulfonamidoaminophene interceptive agents
US3968242A (en) * 1974-08-26 1976-07-06 Mead Johnson & Company Sulfonamidoaminopropiophenone interceptive process
GB1482099A (en) * 1974-12-11 1977-08-03 Wyeth John & Brother Ltd Sulphonamido derivatives
US3966770A (en) * 1975-03-25 1976-06-29 Smithkline Corporation 4-Hydroxy-α-[(3,4-methylenedioxyphenyl)isopropylaminoethyl]-3-(methylsulfonylmethyl)benzyl alcohol
US4044150A (en) * 1976-06-18 1977-08-23 Mead Johnson & Company Antihypertensive 4'-[1-hydroxy-2-[(1-phenoxy ethyl)-amino]ethyl]methanesulfonanilide and salts thereof and therapeutic use
NZ186175A (en) * 1977-01-27 1980-03-05 Shionogi & Co Meta-sulphonamidobenzamide derivatives
GB2077102A (en) * 1980-06-09 1981-12-16 Bristol Myers Co Ophthalmic compositions
US4618624A (en) * 1981-12-02 1986-10-21 American Cyanamid Company 3-amino-4-hydroxy(or alkoxy)phenethanolamine derivatives and pharmacologically-acceptable acid addition salts thereof for increasing the growth rate and/or improving the lean meat to fat ratio of warm-blooded animals
US4404224A (en) * 1981-12-02 1983-09-13 American Cyanamid Company Alkanesulfonanilide derivatives and pharmaceutically acceptable acid addition salts thereof for increasing the growth rate and/or improving the lean meat to fat ratio of warm blooded animals
FR2541999B1 (fr) * 1983-03-04 1986-09-19 Bristol Myers Co Phenethanolamines et leurs utilisations
US4540581A (en) * 1984-01-31 1985-09-10 Bristol-Myers Company Topical nonsteroidal anti-inflammatory compositions and uses
CA1237079A (en) * 1983-05-23 1988-05-24 Arthur Simon Antiarrhythmic class iii process
US5089526A (en) * 1983-05-23 1992-02-18 Bristol-Myers Company Antiarrhythmic class III process
US4657929A (en) * 1983-10-25 1987-04-14 Fisons Plc Compounds
US4507320A (en) * 1983-12-07 1985-03-26 Smithkline Beckman Corporation Dopaminergic agonist N,N-di-n-propyl-4-hydroxy-3-methanesulfonamidophenethylamine
US4574129A (en) * 1984-01-31 1986-03-04 Bristol-Myers Company Topical nonsteroidal anti-inflammatory methods
US5155268A (en) * 1984-05-04 1992-10-13 The Upjohn Company Antiarrhythmic N-aminoalkylene alkyl and aryl sulfonamides
GB8426200D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
US4920116A (en) * 1985-06-28 1990-04-24 Schering A.G. N-(aminoalkyl)-substituted(N or C alkyl)-aryl-4(methylsulfonylamino)benzamides
GB8603120D0 (en) * 1986-02-07 1986-03-12 Pfizer Ltd Anti-dysrhythmia agents
GB8609331D0 (en) * 1986-04-16 1986-05-21 Pfizer Ltd Anti-arrythmia agents
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
GB8707120D0 (en) * 1987-03-25 1987-04-29 Pfizer Ltd Antiarrhythmic agents
US4857651A (en) * 1987-07-29 1989-08-15 American Cyanamid Company α-(2,3-Di(C1 -C4 alkoxy)ethylamino)-β-cyanostyrene and β-nitrostyrene compounds useful as intermediates in the preparation of insecticidal, acaricidal and nematicidal arylpyrroles and method for the preparation thereof
PH25458A (en) * 1987-08-24 1991-07-01 Eisai Co Ltd Piperidine derivatives, therapeutic, preventive agents
GB8909273D0 (en) * 1989-04-24 1989-06-07 Glaxo Group Ltd Chemical compounds
US5405997A (en) * 1989-07-25 1995-04-11 The Upjohn Company Antiarrhythmic methanesulfonamides
US5360822A (en) * 1990-02-07 1994-11-01 Nippon Shinyaku Co. Ltd. Sulfonanilide derivatives and medicine
HU209251B (en) * 1992-03-13 1994-04-28 Synepos Ag Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
ES2122038T3 (es) * 1992-08-26 1998-12-16 Procter & Gamble Correa para la fabricacion de papel con configuracion semicontinua y papel fabricado sobre ella.
US5776983A (en) * 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
US5874475A (en) * 1995-12-21 1999-02-23 Pharmacia & Upjohn Company Antiarrhythmic (S)-enantiomers of methanesulfonamides
US5770615A (en) * 1996-04-04 1998-06-23 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
US6660772B2 (en) 2001-02-01 2003-12-09 Boehringer Ingelheim Pharma Kg Use of 2-amino-1-(4-hydroxy-2-methanesulfonamidophenyl)ethanol for treating urinary incontinence
DE10104369A1 (de) * 2001-02-01 2002-08-08 Boehringer Ingelheim Pharma Verwendung von 2-Amino-(4-hydroxy-2-methansulfonamidophenyl)ethanol zur Behandlung der Harninkontinenz
CN1649614A (zh) 2002-02-22 2005-08-03 新河药品股份有限公司 活性剂传递系统和保护及施用活性剂的方法
JP4901474B2 (ja) 2003-05-30 2012-03-21 ランバクシー ラボラトリーズ リミテッド 置換ピロール誘導体
KR20070104942A (ko) * 2005-02-21 2007-10-29 론자 아게 거울상적으로 순수한 1-치환-3-아미노알코올의 제조 방법
KR101329112B1 (ko) 2005-11-08 2013-11-14 랜박시 래보러터리스 리미티드 (3ｒ,5ｒ)-7-〔2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-〔(4-히드록시 메틸 페닐 아미노)카르보닐〕-피롤-1-일〕-3,5-디히드록시 헵탄산 헤미 칼슘염의 제조 방법
AU2008210637B2 (en) * 2007-01-31 2012-08-16 Toray Industries, Inc. Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes
JP5597992B2 (ja) * 2008-07-31 2014-10-01 東レ株式会社 ベンジルアミン誘導体又はその薬学的に許容される酸付加塩を含有する糖尿病、肥満症、脂質異常症若しくはメタボリックシンドロームの治療剤又は予防剤
EA201100654A1 (ru) 2008-10-22 2012-01-30 Акусела, Инк. Соединения для лечения офтальмологических заболеваний и расстройств
US10793519B2 (en) 2018-05-02 2020-10-06 Academic Pharmaceuticals Incorporated Ultra short acting anti-arrhythmic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH364248A (de) * 1957-12-24 1962-09-15 Geigy Ag J R Verfahren zur Herstellung neuer Aminobenzoesäure-Derivate

Also Published As

Publication number Publication date
FR3027M (fr) 1964-12-28
FR148F (de)
SE334368B (de) 1971-04-26
BR6346374D0 (pt) 1973-05-24
DE1493955B2 (de) 1976-11-18
NL139523B (nl) 1973-08-15
FR95660E (fr) 1971-04-16
US3341584A (en) 1967-09-12
CH475962A (de) 1969-07-31
DE1493955A1 (de) 1971-08-19
FR1599658A (de) 1970-07-20
GB993584A (de)

Similar Documents

Publication Publication Date Title
DK122662B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive sulfonanilider eller syreadditionssalte eller metalsalte deraf.
DK109784C (da) Fremgangsmåde til fremstilling af naphthoxypropanolaminderivater eller syreadditionssalte deraf.
DK108864C (da) Fremgangsmåde til fremstilling af (3-aminopyrazinamido)- guanider eller syreadditionssalte deraf.
DK133372B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive hydroxy-cyclohexyl-aminer eller syreadditionssalte deraf.
DK109037C (da) Fremgangsmåde til fremstilling af 2-alkyl-3-hydroxy-4,5-di-hydroxymethyl-pyridiner eller syreadditionssalte deraf.
DK107357C (da) Fremgangsmåde til fremstilling af basiske estere eller syreadditionssalte deraf.
DK114840B (da) Fremgangsmåde til fremstilling af diaralkylaminer eller syreadditionssalte heraf.
DK111564B (da) Fremgangsmåde til fremstilling af sympathicolytisk virksomme phenoxyalkylguanidiner eller syreadditionssalte heraf.
DK104460C (da) Fremgangsmåde til fremstilling af 2-methyl-3-hydroxypyridiner eller syreadditionssalte deraf.
DK109779C (da) Fremgangsmåde til fremstilling af 3-aminopyrazinamidoguanidinforbindelser eller syreadditionssalte heraf.
DK111894B (da) Fremgangsmåde til fremstilling af diphenylalkylaminer eller syreadditionssalte deraf.
DK115842B (da) Fremgangsmåde til fremstilling af terapeutisk aktive substituerede 4-aminobutynylsuccinimider eller 4-aminobutynylglutarimider eller syreadditionssalte deraf.
DK103672C (da) Fremgangsmåde til fremstilling af phenylpropanolaminer eller syreadditionssalte heraf.
DK106908C (da) Fremgangsmåde til fremstilling af N-(sulfobenzoyl)-N-desulfohepariner eller alkalimetalsalte deraf.
DK114964B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme α-substituerede 1-naftylacetamider eller syreadditionssalte deraf.
DK118189B (da) Analogifremgangsmåde til fremstilling af benzyloxyaminer eller syreadditionssalte heraf.
DK109676C (da) Fremgangsmåde til fremstilling af primære alkylphenylalkylaminer eller syreadditionssalte deraf.
DK104466C (da) Fremgangsmåde til fremstilling af 1-phenyl-2-alkylaminoethanolderivater eller syreadditionssalte deraf.
DK103077C (da) Fremgangsmåde til fremstilling af 4-hydroxyphenyl-4-carbalkoxy-piperidinderivater eller syreadditionssalte deraf.
DK104171C (da) Fremgangsmåde til fremstilling af morfantridinderivater eller syreadditionssalte heraf.
DK100427C (da) Fremgangsmåde til fremstilling af α-pyrrolidinovalerophenoner eller syreadditionssalte deraf.
DK107225C (da) Fremgangsmåde til fremstilling af bis-aralkylaminoalkyl-cyclohexaner eller syreadditionssalte heraf.
DK107418C (da) Fremgangsmåde til fremstilling af phenoxyalkylaminoguanidiner eller syreadditionssalte heraf.
DK100556C (da) Fremgangsmåde til fremstilling af α-pyrrolidinovalerophenoner eller syreadditionssalte deraf.
DK100557C (da) Fremgangsmåde til fremstilling af α-pyrrolidinovalerophenoner eller syreadditionssalte deraf.